 |
pacritinib |
|---|---|
| Trade Name | |
| Orphan Indication | Myelofibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2008-03-13 00:00:00 |
| Sponsor | CTI BioPharma Corporation;3101 Western Avenue, Suite 600;Seattle, Washington, 98121 |
Related Access Program
| |
pacritinib |
|---|---|
| Trade Name | |
| Orphan Indication | Myelofibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2008-03-13 00:00:00 |
| Sponsor | CTI BioPharma Corporation;3101 Western Avenue, Suite 600;Seattle, Washington, 98121 |